Tekla Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-117,717
| Closed | -$2.49M | – | 180 |
|
|
2023
Q1 | $2.49M | Hold |
117,717
| – | – | 0.09% | 114 |
|
|
2022
Q4 | $3M | Buy |
+117,717
| New | +$3M | 0.11% | 100 |
|
|
2022
Q3 | – | Sell |
-56,480
| Closed | -$1.09M | – | 181 |
|
|
2022
Q2 | $1.09M | Hold |
56,480
| – | – | 0.04% | 132 |
|
|
2022
Q1 | $982K | Buy |
+56,480
| New | +$982K | 0.03% | 147 |
|
|
2019
Q2 | – | Sell |
-143,438
| Closed | -$753K | – | 202 |
|
|
2019
Q1 | $753K | Sell |
143,438
-56,562
| -28% | -$297K | 0.03% | 170 |
|
|
2018
Q4 | $890K | Hold |
200,000
| – | – | 0.04% | 167 |
|
|
2018
Q3 | $1.62M | Hold |
200,000
| – | – | 0.06% | 165 |
|
|
2018
Q2 | $1.4M | Hold |
200,000
| – | – | 0.05% | 152 |
|
|
2018
Q1 | $2.85M | Hold |
200,000
| – | – | 0.11% | 120 |
|
|
2017
Q4 | $1.75M | Hold |
200,000
| – | – | 0.07% | 132 |
|
|
2017
Q3 | $2.34M | Hold |
200,000
| – | – | 0.08% | 111 |
|
|
2017
Q2 | $2.79M | Buy |
+200,000
| New | +$2.79M | 0.1% | 102 |
|